Literature DB >> 26796884

Novel regulators and molecular mechanisms of p53R2 and its disease relevance.

E C Cho1, Y Yen2.   

Abstract

p53R2 is a p53-inducible human ribonucleotide reductase subunit involved in critical cellular mechanisms, such as DNA repair, cell cycle arrest, and mitochondrial homeostasis. Molecular investigations and animal studies have revealed functional regulations of p53R2 and its disease relevance. The relationship between p53R2 expression and disease progression in different cancers has been evaluated, and researchers have discovered novel transcription factors and cellular mechanisms that control p53R2 in a p53-independent manner. In addition, p53R2-Mediated mechanisms that affect mitochondria, inflammation, and cancer have been addressed. The role of p53R2 in mitochondria diseases and in cancer is discussed. Finally, p53R2 is taken as a potential target for cancer treatment. This review summarizes the general background, novel regulatory findings, and medical prospect of p53R2.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Inflammation; Mitochondrial diseases; Ribonucleotide reductase; p53R2

Mesh:

Substances:

Year:  2016        PMID: 26796884     DOI: 10.1016/j.biochi.2016.01.008

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  p53R2 is oncogenic in human cervical cancer.

Authors:  Huang Bo; Cai Weiyang; Yanjie Zhang
Journal:  Cell Cycle       Date:  2017-06-28       Impact factor: 4.534

Review 2.  Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update.

Authors:  Marcus J C Long; Phillippe Ly; Yimon Aye
Journal:  Subcell Biochem       Date:  2022

3.  A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome.

Authors:  Ran Jing; James L Corbett; Jun Cai; Gyda C Beeson; Craig C Beeson; Sherine S Chan; David P Dimmock; Lynn Lazcares; Aron M Geurts; John J Lemasters; Stephen A Duncan
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

4.  Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma.

Authors:  Jiewei Chen; Yongbo Xiao; Xiaoyan Cai; Jun Liu; Keming Chen; Xinke Zhang
Journal:  BMC Cancer       Date:  2017-12-15       Impact factor: 4.430

5.  P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.

Authors:  Kathleen M Farmer; Gaurav Ghag; Nicha Puangmalai; Mauro Montalbano; Nemil Bhatt; Rakez Kayed
Journal:  Acta Neuropathol Commun       Date:  2020-08-10       Impact factor: 7.801

6.  Genomic analyses of early responses to radiation inglioblastoma reveal new alterations at transcription,splicing, and translation levels.

Authors:  Saket Choudhary; Suzanne C Burns; Hoda Mirsafian; Wenzheng Li; Dat T Vo; Mei Qiao; Xiufen Lei; Andrew D Smith; Luiz O Penalva
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.